Collaborations & Alliances

NJ Bio, Aji Bio‑Pharma Partner to Support ADC Development 

Expands access to Aji Bio‑Pharma’s site‑specific conjugation platform for NJ Bio’s discovery‑stage and early development clients.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

NJ Bio, Inc., a provider of drug discovery and development services, and Ajinomoto Bio‑Pharma Services (Aji Bio‑Pharma), a provider of biopharmaceutical manufacturing services and platform technologies, entered research collaboration to expand access to AJICAP, Aji Bio‑Pharma’s site‑specific conjugation platform for NJ Bio’s discovery‑stage and early development clients.  This collaboration broadens NJ Bio’s antibody conjugation and linker capabilities to support the development of next‑gen a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters